<strong>Research Progress on Pinocembrin：Potential Therapeutic Applications and Action Mechanisms</strong>

Abstract

Abstract:Pinocembrin is a natural flavonoid compound extracted from propolis，ginger plants，wild marjoram，and other plants which have a higher content. In the preclinical studies，it has shown anti-inflammatory，anti-tumor，antioxidant，decrease blood lipids，neuroprotective effects and other pharmacological effects. In recent domestic and foreign studies focused on pinocembrin neuroprotective effects as well as the ability to attenuate reactive oxygen species，protect the blood-brain barrier，modulate mitochondrial function，and regulate apoptosis. Pinocembrin is a potential drug to treat ischemic stroke and other clinical conditions. In this review，we summarize its pharmacokinetics，mechanisms of action and potential therapeutic applications，in order to provide a reference for pinocembrin mechanisms research and therapeutic applications.

Key words:pinocembrin,pharmacokinetics,therapeutic applications,mechanisms of action,research progress

Zhang Hai-wei，Zhang Li.Research Progress on Pinocembrin：Potential Therapeutic Applications and Action Mechanisms[J]. Acta Neuropharmacologica, 2016, 6(5): 45-52.

References

[1]C Flavia Massaro Inoz, M Katouli, Tanja Grkovic, et al. Anti-staphylococcal activity of C-methyl flavanones from propolis of Australian stinglessbees (Tetragonula carbonari-a)and fruit resins of Corymbia torelliana(Myrtaceae)[J].Fitoterapia, 2014, 03: 024.

[2]Carolina F Danert, Catiana Zampini, Roxana Ordonez, et al. Nutritional and functional properties of aqueous and hydroalcoholic extracts from Argentinean propolis[J].Nat Prod Commun, 2014, 9(2): 167-170.

[3]R.D.Vargas-Sánchez, A.M. Mendoza-Wilson, R.R.Balandran-Quintana, et al. Study of the molecular structure and chemical reactivity of pinocembrin by DFT calculations[J].Comput Theor Chem,2015,1057:21-27.

[4]WU Jun-jun, Zhang Xia, Dong Ming-sheng, et al. Stepwise modular pathway engineering of Escherichia colifor efficient one-step production of (2S)-pinocembrin[J].J Biothchnol, 2016, 231: 183-192.

[5]WU Jun-jun, Zhang Xia, Dong Ming-sheng, et al. Efficient biosynthesis of (2S)-pinocembrin from d-glucose by integrating engineering central metabolic pathways with a pH-shift control strategy[J]. Bioresource Technol, 2016, 218: 999-1007.

[6]Georgina N Diaz Napal, Sara M Palacios. Phytotoxicity of secondary metabolites isolated from Flourensia oolepis S.F.Blake[J].Chem Biodivers, 2013, 10(7): 1295-1304.

[7]Yuan Yue, Yang Qing-yun, Tong Yuan-feng, et al. Synthesis and enantiomeric resolution of (+/-)-pinocembrin[J].J Asian Nat Prod Res, 2008, 10(9-10): 999-1002.

[8]Muhammed A Saad, Rania Abdel Salam R M, Kenawy S A, et al. Pinocembrin attenuates hippocampal inflammation,oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusion[J].Pharmacological reports: PR, 2015, 67: 115-122.

[9]Yang Zhi-hong, Sun Xiao, Yun Qi, et al. Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood-brain barrier in vitro cell experiments[J].J Asian Nat Prod Res, 2012,14(1):14-21.

[10]Yan Bei, Cao Guo-ying, Sun Tao-hua, et al. Determination of pinocembrin in human plasmaby solidphase extraction and LC/MS/MS: application to pharmacokinetic studies[J].Biomed Chromatogr, 2014, Doi: 10.1002/bmc.3186.

[11]Wang Y J. National Institutes of Health Phase II study of pinocembrin injection to treat ischemic stroke[J/OL].ClinicalTrials.gov,2014.http://www.clinicaltrials.gov/ct2/show/NCT02059785?term=pinocembrin&rank=1.

[12]Yang Zhi-hong, Liu Rui, Li Xiao-xiu, et al. Development and validation of a high-performance liquid chromatographic method for determination of pinocembrin in rat plasma: application to pharmacokinetic study[J].Pharm Biomed Anal, 2009, 49(5): 1277-1281.

[13]Chiral L Sayre, Jody K Takemoto, Stephanie E Martinez, et al. Chiral analytical method development and application to preclinical pharmacokinetics of pinocembrin[J]. Biomed Chromatogr, 2013, 27(6): 681-684.

[14]Liu Y L, Ho David K, John M Cassady, et al. Isolation of potential cancer chemopreventive agents from Eriodictyon californicum[J].J Nat Prod, 1992, 55(3): 357-363.

[15]Bernd Weisshaar, Gareth I Jenkins. Phenylpropanoid biosynthesis and its regulation[J]. Curr Opin Plant Biol, 1998, 1(3): 251-257.

[16]Masafumi Kaneko, Eui ILHwang, Yasuo Ohnishi, et al. Heterologous production of flavanones in Escherichia coli:potential for combinatorial biosynthesis of flavonoids in bacteria[J].J Ind Microbiol Biotechnol, 2003, 30(8): 456-461.

[17]Yan Ya-jun, Abhijeet Kohli, Mattheos A G Koffas. Biosynthesis of natural flavanones in Saccharomyces cerevisiae[J].Appl Environ Microbiol, 2005, 71(9): 5610-5613.

[18]Bong-Gyu Kim, Lee Hyejin, Joong-Hoon Ahn. Biosynthesis of pinocembrin from glucose using engineered Escherichia coli[J]. J Microbiol Biotechnol, 2014, 24(11): 1536-1541.

[19]Dariush Mozaffarian, Emelia J Benjamin, Alan S Go, et al. Executive summary: heart disease and stroke statistics 2015 update: a report from the American Heart Association[J]. Circulation, 2015, 131(4): 434-441.

[20]Shi Li-li, Chen Bai-nian, Gao Mei, et al. The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats[J].Life Sci, 2011, 88(11-12): 521-528.

[21]Gao Mei, Zhang Wen-cui, Liu Qing-shan, et al. Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio[J].Eur J P-harmacol, 2008, 591(1-3): 73-79.

[22]Hiroshi Izuta, Masamitsu Shimazawa, Shigemi Tazawa, et al. Protective effects of Chinese propolis and its component, chrysin, against neuronal cell death via inhibition of mitochondrial apoptosis pathway in SH-SY5Y cells[J]. J Agric Food Chem, 2008, 56(19): 8944-8953.

[23]Liu R, Gao M, Yang Z H, et al. Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro[J].Brain Res,2008,1216:104-115.

[24]Gao Mei, Zhu Shen-yin, Tan Chu-bing, et al. Pinocembrin protects the neurovascular unit by reducing inflammation and extracellular proteolysis in MCAO rats[J].J Asian Nat Prod Res, 2010, 12(5): 407-418.

[25]Gao Mei, Liu Rui, Zhu Shen-yin, et al. Acute neurovascular unit protective action of pi-nocembrin against permanent cerebral ischemia in rats[J].J Asian Nat Prod Res, 2008, 10(5-6): 551-558.

[26]Wang Shou-bao, Pang Xiao-bin, Gao Mei, et al. Pinocembrin protects rats against cerebral ischemic damage through soluble epoxide hydrolase and epoxyeicosatrienoic acids[J].Chin J Nat Med, 2013, 11(3): 207-213.

[27]Jeffrey J Iliff, Nabil J Alkayed. Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent[J].Future Neurol, 2009, 4(2): 179-199.

[28]Koichi Node, Huo Yu-qing, Ruan Xiu-lu, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids[J].Science, 1999, 285(5431): 1276-1279.

[29]Jorge H Capdevila, John R Falck. The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation[J]. Biochem Biophys Res Commun, 2001, 285(3): 571-576.

[30]John D Imig, Alexis N Simpkins, Marija Renic. Cytochrome P450 eicosanoids and cerebral vascular function[J]. Expert Rev Mol Med, 2011, 13: e7.

[31]Jeremy Bellien, Robinson Joannides. Epoxyeicosatrienoic acid pathway in human health and diseases[J].J Cardiovasc Pharmacol, 2013, 61(3): 188-196.

[32]Priyanka Sura, Radhakrishna Sura, Ahmed E Enayetallah, et al. Distribution and expression of soluble epoxide hydrolase in human brain[J].J Histochem Cytochem, 2008, 56(6): 551-559.

[33]Sari A Jouihan, Kristen L Zuloaga, Zhang Wen-ri, et al. Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus[J].J Cereb Blood Flow Metab, 2013, 33(10): 1650-1656.

[34]Zhang Wen-ri, Ines P Koerner, Ruediger Noppens, et al. Soluble epoxide hydrolase: a novel therapeutic target in stroke[J].J Cereb Blood Flow Metab, 2007, 27(12): 1931-1940.

[35]Zhang Wen-ri, Takashi Otsuka, Nobuo Sugo, et al. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia[J].Stroke, 2008, 39(7): 2073-2078.

[36]Jafar Sadik Shaik, Muzamil Ahmad, Li Wen-jin, et al. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke[J].Am J Physiol Heart Circ Physiol, 2013, 305(11): H1605-H1613.

[37]Christian Brenneis, Marco Sisignano, Ovidiu Coste, et al. Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation[J].Mol Pain, 2011, 7: 78.

[38]Wu Cai-xia, Liu Rui, Gao Mei, et al. Pinocembrin protects brain against ischemia/reperfusion injury by attenuating endoplasmic reticulum stress induced apoptosis[J].Neurosci Lett, 2013, 546: 57-62.

[39]Meng Fan-rui, Liu Rui, Gao Mei, et al. Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats[J].Brain Res, 2011, 1391: 93-101.

[40]Muhammed A Saad, Rania M Abdel Salam, Sanaa A Kenawy, et al. Pinocembrin attenuates hippoca-mpal inflammation, oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusion[J].Pharmacol Rep, 2015, 67(1): 115-122.

[41]Shi Li-li, Chen Bai-nian, Gao Mei, et al. The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats[J].Life Sci, 2011, 88(11-12): 521-528.

[42]Denise M Boudreau, Gregory F Guzauskas, Chen Er, et al. Cost-effectiveness of recombinant tissuetype plasminogen activator within 3 hours of acute ischemic stroke: current evidence[J].Stroke, 2014, 45(10): 3032-3039.

[43]Liu Rui, Wu Cai-xia, Zhou Dan, et al. Pinocembrin protects against beta-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis[J].BMC Med, 2012, 10: 105.

[44]Liu Rui, Li Jin-ze, Song Jun-ke, et al. Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits[J].Neurobiol Aging, 2014, 35(6):1275-1285.

[45]Wang Yu-min, Miao Ying-chun, Aamina Zia Mir, et al. Inhibition of beta-amyloid-induced neurotoxicity by pinocembrin through Nrf2/HO-1pathway in SH-SY5Y cells[J]. J Neurol Sci, 2016, 368: 223-230.

[46]Wang Yu-min, Gao Jun-hong, Miao Ying-chun, et al. Pinocembrin protects SH-SY5Y cells against MPP(+)-induced neurotoxicity through the mitochondrial apoptotic pathway[J].J Mol Neurosci, 2014, 53(4): 537-545.

[47]Wang H Q, Wang Y M, Zhao L N, et al. Pinocembrin attenuates MPP+-induced neurotoxicity by the induction of heme oxygenase-1 through ERK1/2 pathway[J].Neurosci Lett, 2016, 612: 104-109.

[48]Jin Xiao-hua, Liu Qian, Jia Li-li, et al. Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells[J].Cell Mol Neurobiol, 2014, 35: 323-333..

[49]Li Li, Yang Hai-guang, Yuan Tian-yi, et al. Rho kinase inhibition activity of pinocembrin in rat aortic rings contracted by angiotensin II[J].Chin J Nat Med, 2013, 11(3): 258-263.

[50]Sang Hui, Yuan Na, Yao Shu-tong, et al. Inhibitory effect of the combination therapy of simvastatin and pinocembrin on atherosclerosis in ApoE-deficient mice[J].Lipids Health Dis, 2012, 11:166.

[51]袁娜. 乔松素对ApoE-/-小鼠动脉粥样硬化影响的实验研究[D].泰山：泰山医学院，2010.

[52]Yang Nana, Qin Shu-cun, Wang Meng-zan, et al. Pinocembrin,a major flavonoid in propolis, improves the biological functions of EPCs derived from rat bone marrow through the PI3K-eNOS-NO signaling pathway[J].Cytotechnology, 2013, 65(4): 541-551.

[53]李伟，李冬娟，杨艳. 乔松素对脂多糖诱导的人脐静脉内皮细胞凋亡的影响[J].中国动脉粥样硬化杂志, 2010, 18(5): 351-354.

[54]Lamiaa A Ahmed, Sherine M Rizk, Shohda A EL-Maraghy. Pinocembrin ex vivo preconditioni-ng improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats[J].Biochem Pharmacol, 2017, 138: 193-204.

[55]Lanan Wassy Soromou, Chu Xiao, Jiang Lan-xiang, et al. In vitro and in vivo protection providedby pinocembrin against lipopolysaccharide-induced inflammatory responses[J]. Int Immunopharmacol, 2012, 14(1): 66-74.

[56]Zhou Lu-ting, Wang Ke-jia, Li Ling, et al. Pinocembrin inhibits lipopolysaccharide-induced inflammatory mediators production in BV2 microglial cells through suppression of PI3K/Akt/NF-κB pathway[J].Eur. J. Pharmacol, 2015, 761: 211-216.

[57]Soromou L W, Jiang L, Wei M, et al. Protection of mice against lipopolysaccha-ride-induced endotoxic shock by pinocembrin is correlated with regulation of cytokine secretion[J].J Immunotoxicol, 2014, 11(1): 56-61.

[58]兰那. 乔松素抗金黄色葡萄球菌感染和抗炎作用及机制的研究[D].长春：吉林大学, 2013.

[59]Sib S G, Shib S S, Venkatachalam S, et al. Pinocembrin attenuates lipopolysacc-haride-induced inflammatory responses in Labeorohita macrophages via the suppression of the NF-κB signalling pathway[J].Fish Shellfishi Immun, 2016, 56: 459-466.

[60]Metzner J, Schneidewind E M, Friedrich E. Effect of propolis and pinocembrin on fungi[J].Pharmazie, 1977, 32(11): 730.

[61]Araceli Sala, M Carmen Recio, Guillermo R Schinella, et al. Assessment of the anti-inflammatory activity and free radical scavenger activity of tiliroside[J].Eur J Pharmacol, 2003, 461(1): 53-61.

[62]Metzner J, Schneidewind E M. Effect of pinocembrin on the course of experimental candida infections in mice[J].Mykosen, 1978, 21(8): 257-262.

[63]Atac Uzel, Kadri Sorkun, Ozant Oncag, et al. Chemical compositions and antimicrobial activities of four different Anatolian propolis samples[J].Microbiol Res, 2005, 160(2): 189-195.

[64]David R Katerere, Alexander I Gray, Robert J Nash, et al. Phytochemical and antimicrobial investigations of stilbenoids and flavonoids isolated from three species of Combretaceae[J].Fitoterapia, 2012, 83(5): 932-940.

[65]Leticia M Estevinho, Ana Paula Pereira, Leandro Moreira, et al. Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey[J].Food Chem Toxicol, 2008, 46(12): 3774-3779.

[66]Mariana Peralta, Maximiliano Calise, M Cecilia Fornari, et al. A prenylated flavanone from Dalea elegans inhibits rhodamine 6 G efflux and reverses fluconazole-resistance inCandida albicans[J]. Planta Med, 2012, 78(10): 981-987.

[67]Ahmed G Hegazi, Faten K Abd EI Hady, Fayrouz A M Abd Allah. Chemical composition and anti-microbial activity of European propolis[J].Z Naturforsch C, 2000, 55(1-2): 70-75.

[68] Yong K Park, Michel H Koo, Jose A S Abreu, et al. Antimicrobial activity of propolis on oral-microorganisms[J].Curr Microbiol, 1998, 36(1): 24-28.

[69]Leticia Barrientos, Christian L Herrera, Gloria Montenegro, et al. Chemical and botanical characterization of Chilean propolis and biological activity on cariogenic bacteria Streptococcus mutans and Streptococcus sobrinus[J]. Braz J Microbiol, 2013, 44(2): 577-585.

[70]Patrick Ruddock, Marijo Charland, Sandra Ramirez, et al. Antimicrobial activity of flavonoids from Piper lanceaefolium and other Colombian medicinal plants against antibiotic susceptible and resistant strains of Neisseria gonorrhoeae[J].Sex Transm Dis, 2011, 38(2): 82-88.

[71]Soromou Lanan Wassy, Zhang Yu, Cui Yi-wen, et al. Subinhibitory concentrations of pinocembrin exert anti-Staphylococcus aureus activity by reducing alpha-toxinBexpression[J].J Appl Microbiol, 2013, 115(1): 41- 49.

Research Progress on Pinocembrin：Potential Therapeutic Applications and Action Mechanisms

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles8

Recommended Articles

Metrics

[1]	ZHANG Jian-mei, ZHANG Dan-shen.Advances in Research on Treatment of Ulcerative Colitis with Chinese and Western Medicine[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 43-47.
[2]	ZHANG Hao-nan, YANG Hui.Recent Advances in the Research of the Protective Effect of Natural Drugs on Cerebral Ischemia-Reperfusion Injury[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 14-20.
[3]	JIN Shan, ZHANG Dan-shen.Research Progress of Lidocaine Transdermal Preparations[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 16-20.
[4]	BIAN Fang1，HOU Yan-ning2.Research Progress of the ATP Sensitive Potassium Channels in Neurodegenerative Diseases[J]. Acta Neuropharmacologica, 2017, 7(5): 52-58.
[5]	QIN Xue-qing，YANG Zhi-hong，SUN Xiao-bo.A Review of Studies on Blood Brain Barrier in vitro Model[J]. Acta Neuropharmacologica, 2016, 6(1): 25-34.
[6]	WANG Ying-ying, SONG Xiu-yun, WANG Qi, CHEN Nai-hong.Application of Natural Antioxidants in the Progress of Alzheimer's Disease[J]. Acta Neuropharmacologica, 2015, 5(6): 30-34.
[7]	MEI Yan-fei, ZHANG Dan-shen.Pharmacological Actions and Therapeutic Applications of Tanshinone ⅡA[J]. ACTA NEUROPHARMACOLOGICA, 2014, 4(5): 55-64.
[8]	MEI Yan-fei, ZHANG Li.Effects of Osthole on the Nervous System and its Pharmacokinetics[J]. ACTA NEUROPHARMACOLOGICA, 2014, 4(3): 57-64.